Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Glatiramer acetate exemplifies therapeutic exploitation of molecular mimicry: it mimics myelin basic protein structure to modulate autoimmune responses central to multiple sclerosis pathology. Its main actions include shifting the balance toward anti-inflammatory immunity and inducing regulatory mechanisms that protect CNS myelin from further damage.
Immune modulation via molecular mimicry with MBP; induction/activation of regulatory Th2/Treg cells; competition for MHC binding; partial activation/tolerance induction.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Immune System Modulation via Myelin Basic Protein Mimicry.